Drug Discovery for Adult Cardiomyocyte Regeneration: Opportunities and Challenges
Antioxidants & Redox Signaling · 2023
DOI: 10.1089/ars.2023.0319 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, 2023. Verfasst von Xu Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Myocardial Infarction. Die Arbeit nennt 88 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- Institute of Precision Medicine, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Zitieren
APA
Zhao, X., Li, D., Song, Y., Xu, J., & Xiang, F. L. (2023). Drug Discovery for Adult Cardiomyocyte Regeneration: Opportunities and Challenges. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2023.0319
Vancouver
Zhao X, Li D, Song Y, Xu J, Xiang FL. Drug Discovery for Adult Cardiomyocyte Regeneration: Opportunities and Challenges. Antioxidants & Redox Signaling. 2023. doi:10.1089/ars.2023.0319
BibTeX
@article{Zhao2023,
author = {Zhao, Xu and Li, Donghua and Song, Yiyan and Xu, Jie and Xiang, Fu-Li},
title = {Drug Discovery for Adult Cardiomyocyte Regeneration: Opportunities and Challenges},
journal = {Antioxidants & Redox Signaling},
year = {2023},
doi = {10.1089/ars.2023.0319}
}
EUVIMED